BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
305 hedge funds and large institutions have $7.35B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2022 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 114 increasing their positions, 112 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% less capital invested
Capital invested by funds: $8.37B → $7.35B (-$1.03B)
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
Holders
305
Holding in Top 10
10
Calls
$115M
Puts
$93.6M
Top Buyers
| 1 | +$154M | |
| 2 | +$89.7M | |
| 3 | +$85.3M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$73.2M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$58.6M |
Top Sellers
| 1 | -$275M | |
| 2 | -$60.6M | |
| 3 | -$47.1M | |
| 4 |
BAMCO Inc
New York
|
-$27.3M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$24.8M |